CN Stock MarketDetailed Quotes

688266 Suzhou Zelgen Biopharmaceuticals

Watchlist

66.07
+1.02+1.57%

Market Closed Jan 24 15:00 CST

17.49BMarket Cap-100.26P/E (TTM)

Suzhou Zelgen Biopharmaceuticals Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Suzhou Zelgen Biopharmaceuticals Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 3 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: CNY

Actual

Estimate

Date	Period	Revenue/Estimate	Earnings Call
--	2025/FY	-- / 1.221B	--
--	2024/FY	-- / 600.000M	--
--	2023/FY	386.439M / 429.000M	--
--	2021/FY	201.107M / 208.000M	--
--	2020/FY	27.661M / 0.000	--

DatePeriodRevenue/EstimateEarnings Call

--2025/FY-- / 1.221B--

--2024/FY-- / 600.000M--

--2023/FY386.439M / 429.000M--

--2021/FY201.107M / 208.000M--

--2020/FY27.661M / 0.000--

Unlock Free Earnings Estimates

Open Account

Suzhou Zelgen Biopharmaceuticals Earnings Reports

Zejing Pharmaceutical 2024 annual results forecast

Jan 17 11:00 ET

Zejing Pharmaceutical Report for the Third Quarter of 2024

Oct 25, 2024 12:00 ET

ZeJing Pharmaceutical's 2024 interim report

Aug 23, 2024 12:00 ET

Summary of Zejing Pharmaceuticals' semi-annual report for 2024